Granules India Limited (GRANULES.NS)
INR 596.4
(-0.07%)
INR 596.4
(-0.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.31 Billion INR | -30.1% |
| 2022 | 14.75 Billion INR | 23.62% |
| 2021 | 11.93 Billion INR | 16.37% |
| 2020 | 10.25 Billion INR | 27.38% |
| 2019 | 8.05 Billion INR | 20.14% |
| 2018 | 6.7 Billion INR | 32.42% |
| 2017 | 5.06 Billion INR | 6.71% |
| 2016 | 4.74 Billion INR | 35.29% |
| 2015 | 3.5 Billion INR | 17.53% |
| 2014 | 2.98 Billion INR | 17.73% |
| 2013 | 2.53 Billion INR | 12.22% |
| 2012 | 2.25 Billion INR | 25.03% |
| 2011 | 1.8 Billion INR | 284.63% |
| 2010 | 469.37 Million INR | 2.6% |
| 2009 | 457.47 Million INR | 0.0% |
| 2008 | - INR | -100.0% |
| 2007 | 263.82 Million INR | 55.88% |
| 2006 | 169.24 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.72 Billion INR | -8.78% |
| 2023 Q2 | 4.53 Billion INR | 8.4% |
| 2023 FY | 10.31 Billion INR | -30.1% |
| 2023 Q1 | 4.18 Billion INR | 6.66% |
| 2023 Q4 | 2.98 Billion INR | -35.07% |
| 2023 Q3 | 4.6 Billion INR | 1.38% |
| 2022 Q2 | 3.73 Billion INR | 10.51% |
| 2022 FY | 14.75 Billion INR | 23.62% |
| 2022 Q4 | 3.92 Billion INR | 5.7% |
| 2022 Q3 | 3.71 Billion INR | -0.52% |
| 2022 Q1 | 3.37 Billion INR | 48.78% |
| 2021 Q1 | 2.98 Billion INR | 63.06% |
| 2021 FY | 11.93 Billion INR | 16.37% |
| 2021 Q3 | 3.3 Billion INR | -2.96% |
| 2021 Q2 | 3.4 Billion INR | 13.95% |
| 2021 Q4 | 2.27 Billion INR | -31.25% |
| 2020 Q2 | 2.76 Billion INR | -4.1% |
| 2020 Q1 | 2.88 Billion INR | 112.81% |
| 2020 Q4 | 1.83 Billion INR | -34.29% |
| 2020 Q3 | 2.78 Billion INR | 0.77% |
| 2020 FY | 10.25 Billion INR | 27.38% |
| 2019 Q1 | 2.09 Billion INR | 53.68% |
| 2019 FY | 8.05 Billion INR | 20.14% |
| 2019 Q2 | 2.26 Billion INR | 8.09% |
| 2019 Q3 | 2.32 Billion INR | 2.6% |
| 2019 Q4 | 1.35 Billion INR | -41.75% |
| 2018 Q3 | 1.86 Billion INR | -1.49% |
| 2018 Q2 | 1.89 Billion INR | 19.69% |
| 2018 FY | 6.7 Billion INR | 32.42% |
| 2018 Q1 | 1.58 Billion INR | -7.51% |
| 2018 Q4 | 1.36 Billion INR | -26.71% |
| 2017 Q4 | 1.7 Billion INR | 15.94% |
| 2017 Q3 | 1.47 Billion INR | 7.93% |
| 2017 Q2 | 1.36 Billion INR | -2.06% |
| 2017 FY | 5.06 Billion INR | 6.71% |
| 2017 Q1 | 1.39 Billion INR | -4.92% |
| 2016 FY | 4.74 Billion INR | 35.29% |
| 2016 Q2 | 948.16 Million INR | 1.63% |
| 2016 Q4 | 1.46 Billion INR | 40.55% |
| 2016 Q1 | 932.98 Million INR | -18.38% |
| 2016 Q3 | 1.04 Billion INR | 10.04% |
| 2015 Q4 | 1.14 Billion INR | 25.39% |
| 2015 FY | 3.5 Billion INR | 17.53% |
| 2015 Q3 | 911.55 Million INR | 4.27% |
| 2015 Q2 | 874.2 Million INR | 1.94% |
| 2015 Q1 | 857.57 Million INR | 14.2% |
| 2014 Q1 | 694.2 Million INR | 4.64% |
| 2014 Q2 | 757.61 Million INR | 9.13% |
| 2014 Q3 | 779.47 Million INR | 2.89% |
| 2014 Q4 | 750.96 Million INR | -3.66% |
| 2014 FY | 2.98 Billion INR | 17.73% |
| 2013 Q2 | 669.86 Million INR | 27.26% |
| 2013 Q1 | 526.39 Million INR | -59.56% |
| 2013 FY | 2.53 Billion INR | 12.22% |
| 2013 Q4 | 663.44 Million INR | -1.47% |
| 2013 Q3 | 673.37 Million INR | 0.52% |
| 2012 Q3 | 320.07 Million INR | -4.01% |
| 2012 Q4 | 1.3 Billion INR | 306.68% |
| 2012 Q1 | 301.54 Million INR | 0.0% |
| 2012 FY | 2.25 Billion INR | 25.03% |
| 2012 Q2 | 333.43 Million INR | 10.58% |
| 2011 FY | 1.8 Billion INR | 284.63% |
| 2010 FY | 469.37 Million INR | 2.6% |
| 2009 FY | 457.47 Million INR | 0.0% |
| 2008 FY | - INR | -100.0% |
| 2007 FY | 263.82 Million INR | 55.88% |
| 2006 FY | 169.24 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -1678.415% |
| Ind-Swift Limited | 946.56 Million INR | -989.495% |
| Bajaj HealthCare Limited | 985.34 Million INR | -946.618% |
| Sakar Healthcare Limited | 204.07 Million INR | -4953.337% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 81.471% |
| Innova Captab Limited | 931.03 Million INR | -1007.676% |
| Divi's Laboratories Limited | 14.17 Billion INR | 27.221% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -316.931% |
| Morepen Laboratories Limited | 1.98 Billion INR | -418.896% |
| Mankind Pharma Limited | 29.27 Billion INR | 64.77% |
| Sequent Scientific Limited | 2.9 Billion INR | -255.392% |
| Wanbury Limited | 978.96 Million INR | -953.438% |
| Laurus Labs Limited | 11.9 Billion INR | 13.409% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1005.693% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 11.407% |
| Alembic Limited | 872.45 Million INR | -1082.04% |
| Hikal Limited | 4.46 Billion INR | -131.032% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 35.016% |
| Neuland Laboratories Limited | 2.92 Billion INR | -252.003% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 30.284% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 78.036% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -368.551% |
| Themis Medicare Limited | 1.12 Billion INR | -816.044% |
| RPG Life Sciences Limited | 1.63 Billion INR | -530.559% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 91.764% |
| Lupin Limited | 125.09 Billion INR | 91.756% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -392.484% |
| Wockhardt Limited | 8.48 Billion INR | -21.613% |
| Vaishali Pharma Limited | 84.02 Million INR | -12172.906% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -235.441% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -2251.568% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 28.651% |
| FDC Limited | 3.49 Billion INR | -194.672% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 89.244% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -2400.515% |
| Eris Lifesciences Limited | 4.94 Billion INR | -108.637% |
| Venus Remedies Limited | 1.91 Billion INR | -438.167% |
| ZIM Laboratories Limited | 1.01 Billion INR | -917.987% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -626.652% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -17592.83% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -374.261% |
| Shilpa Medicare Limited | 3.33 Billion INR | -209.306% |
| Albert David Limited | 1.02 Billion INR | -905.002% |
| Ajanta Pharma Limited | 30.46 Billion INR | 66.146% |
| Hester Biosciences Limited | 908.84 Million INR | -1034.721% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -635.164% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -303.774% |
| Gufic Biosciences Limited | 1.18 Billion INR | -769.113% |
| Windlas Biotech Limited | 1 Billion INR | -924.61% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -244.288% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -72458.925% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -6256.979% |
| Aarti Drugs Limited | 1.16 Billion INR | -783.339% |
| Bal Pharma Limited | 555.62 Million INR | -1756.069% |
| Alkem Laboratories Limited | 32.83 Billion INR | 68.592% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 93.311% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -860.057% |
| Medicamen Biotech Limited | 335.16 Million INR | -2976.914% |
| Unichem Laboratories Limited | 6.72 Billion INR | -53.33% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -2163.639% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -151114.076% |
| Valiant Laboratories Limited | 138.02 Million INR | -7371.473% |
| Orchid Pharma Limited | 800.77 Million INR | -1187.859% |
| Medico Remedies Limited | 59.67 Million INR | -17181.609% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -385.495% |
| Ipca Laboratories Limited | 18.98 Billion INR | 45.687% |
| Brooks Laboratories Limited | 51.18 Million INR | -20050.059% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -2883.743% |
| Piramal Enterprises Limited | 63.65 Billion INR | 83.798% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 51.859% |
| NATCO Pharma Limited | 10.05 Billion INR | -2.533% |
| Suven Life Sciences Limited | 109.75 Million INR | -9296.629% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -22243.357% |
| Strides Pharma Science Limited | 9.16 Billion INR | -12.557% |
| Indoco Remedies Limited | 12.06 Billion INR | 14.496% |
| Alpa Laboratories Limited | 127.38 Million INR | -7996.09% |
| Lasa Supergenerics Limited | 291.17 Million INR | -3441.8% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -235.179% |